Evaluating the medical evidence for quality improvement

Clinics in Perinatology

Volumn 37, Issue 1, 2010, Pages 11-28

  Soll, Roger F ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Evidence based medicine; Neonatology; Randomized controlled trials

Indexed keywords

CHLORAMPHENICOL; CORTICOSTEROID; INDOMETACIN; SULFONAMIDE;

BODY GROWTH; BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBRAL PALSY; CHRONIC LUNG DISEASE; CLINICAL DECISION MAKING; CLINICAL TRIAL; DIGESTIVE SYSTEM PERFORATION; DRUG MECHANISM; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; GASTROINTESTINAL HEMORRHAGE; GRAY BABY SYNDROME; HEALTH CARE POLICY; HIGH FREQUENCY VENTILATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; INDUCED HYPOTHERMIA; INFECTION; INTERMETHOD COMPARISON; KERNICTERUS; LUNG INJURY; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN CARE; NEWBORN DISEASE; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLISHING; QUALITY OF LIFE; RETROLENTAL FIBROPLASIA; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SIDE EFFECT; SURVIVAL RATE; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; EVALUATION STUDIES AS TOPIC; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; NEONATOLOGY; PRACTICE GUIDELINES AS TOPIC; QUALITY ASSURANCE, HEALTH CARE;

EID: 77950965599     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2010.01.002     Document Type: Review

References (51)

1. Horbar J.D., Badger G.J., Carpenter J.H., et al. Members of the Vermont Oxford Network. Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics 2002, 110(1 Pt 1):143-151.
2. Silverman W.A. Human experimentation in perinatology. Clin Perinatol 1987, 14:403-416.
3. Soll R.F., Andruscavage L. Section 1: evidence-based quality improvement, principles, and perspectives: the principles and practice of evidence-based neonatology. Pediatrics 1999, 103(1 Suppl E):215-224.
4. Horbar J.D., Badger G.J., Lewit E.M., et al. Hospital and patient characteristics associated with variation in 28-day mortality rates for very low birth weight infants. Vermont Oxford Network. Pediatrics 1997, 99(2):149-156.
5. VON Annual Data 2008. Available at: http://www.vtoxford.org.
6. Sackett D.L., Rosenberg W.M., Gray J.A., et al. Evidence-based medicine what it is and what it isn't [editorial]. Br Med J 1996, 312:71-72.
7. Akobeng A.K. Principles of evidence based medicine. Arch Dis Child 2005, 90:837-840.
8. Sackett D.L., Richardson W.S., Rosenberg W., et al. Evidence-based medicine. How to practice and teach EBM 2000, Churchill Livingston, London, England. 2nd edition.
9. Richardson W.S., Wilson M.C., Nishikawa J., et al. The well-built clinical question: a key to evidence-based decisions. ACP J Club 1995, 123:Al2-A13.
10. Haynes R.B., Wilczynski N.L., McKibben K.A., et al. Developing optimal search strategies for detecting clinically sound studies in MEDLINE. J Am Med Inform Assoc 1994, 1:447-458.
11. Sinclair J.C., Bracken M.B., Horbar J.D., et al. Introduction to neonatal systematic reviews. Pediatrics 1997, 100:892-895.
12. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.0.2 [updated September 2009]. The Cochrane Collaboration. 2009. Available at: Accessed November 15, 2009. http://www.cochrane-handbook.org.
13. Preventive Services Resource Links U.S. Preventive services task force. Agency for healthcare research and quality 2009, Rockville (MD),, Available at:, Accessed November 15, 2009. http://www.ahrq.gov/clinic/uspstf/resource.htm.
14. Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol 1929, 10(31):226-236.
15. Chalmers I., Enkin M., Keirse M.J.N.C. Effective care in pregnancy and childbirth 1989, Oxford University Press, Oxford, UK.
16. Nuland Sherwin B. The doctors' plague: germs, childbed fever, and the strange story of Ignác Semmelweis. Great discoveries series 2003, W.W. Norton, New York.
17. Ohlsson A. Randomized controlled trials and systematic reviews: a foundation for evidence-based perinatal medicine. Acta Paediatr 1996, 85:647-655.
18. Feinstein A.R. An additional basic science for clinical medicine: II. The limitations of randomized trials. Ann Intern Med 1983, 99:544-550.
19. Chalmers T.C., Celano P., Sacks H.S., et al. Bias in treatment assignment in controlled clinical trials. N Engl J Med 1983, 309(22):1358-1361.
20. Beecher H.K. The powerful placebo. JAMA 1955, 159:1602-1606.
21. Cook D.J., Mulrow C.D., Haynes R.B. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 1997, 126(5):376-380.
22. Cunningham A.S. Meta-analysis and methodology review: what's in a name?. J Pediatr 1988, 113:328-329.
23. Sinclair J.C., Bracken M.B. Effective care of the newborn infant 1992, Oxford University Press, Oxford, UK.
24. LeLorier J., Gregoire G., Benhaddad A., et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997, 337:536-542.
25. Muir Gray J.A. Evidence-based healthcare 1997, Churchill Livingstone, London, England.
26. Guyatt G.H., Oxman A.D., Vist G.E., et al. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926.
27. Guyatt G.H., Oxman A.D., Kunz R., et al. GRADE Working Group. What is " quality of evidence" and why is it important to clinicians?. BMJ 2008, 336:995-998.
28. Guyatt G.H., Oxman A.D., Kunz R., et al. GRADE Working Group. Going from evidence to recommendations. BMJ 2008, 336:1049-1051.
29. Guyatt G.H., Oxman A.D., Kunz R., et al. GRADE Working Group. Incorporating considerations of resources use into grading recommendations. BMJ 2008, 336:1170-1173.
30. Horbar J.D. The Vermont Oxford Network: evidence-based quality improvement for neonatology. Pediatrics 1999, 103(1 Suppl E):350-359.
31. Plsek P.E. Quality improvement methods in clinical medicine. An overview of quality improvement methods in healthcare. Pediatrics 1999, 103(1 Suppl E):203-214.
32. Horbar J.D., Rogowski J., Plsek P.E., et al. Collaborative quality improvement for neonatal intensive care. NIC/Q project investigators of the Vermont Oxford Network. Pediatrics 2001, 107(1):14-22.
33. Horbar J.D., Plsek P.E., Leahy K., NIC/Q 2000 NIC/Q 2000: establishing habits for improvement in neonatal intensive care units. Pediatrics 2003, 111(4 Pt 2):e397-e410.
34. Liggins G.C., Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972, 50(4):515-525.
35. Crowley P., Chalmers I., Keirse M.J. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990, 97(1):11-25.
36. Roberts D., Dalziel S.R. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006, (3). CD004454. DOI:10.1002/14651858.CD004454.pub2.
37. Sinclair J.C. Meta-analysis of randomized controlled trials of antenatal corticosteroids for the prevention of respiratory distress syndrome: discussion. Am J Obstet Gynecol 1995, 173:335-344.
38. NIH Consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995, 273:413-418.
39. Wright L.L., Merenstein G.B., Goldenberg R.L., et al. Impact of the NIH consensus development conference on corticosteroids for fetal maturation: change in obstetric attitudes [abstract]. Pediatr Res 1996, 39:254.
40. Fanaroff A.A., Hack M., Walsh M.C. The NICHD neonatal research network: changes in practice and outcomes during the first 15 years. Semin Perinatol 2003, 27:281-287.
41. Bancalari E. Corticosteroids and neonatal chronic lung disease. Eur J Pediatr 1998, 157(Suppl 1):S31-S37.
42. Halliday H.L., Ehrenkranz R.A., Doyle L.W. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2009, (1). CD001146. DOI:10.1002/14651858.CD001146.pub2.
43. Committee on Fetus and Newborn Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002, 109(2):330-338.
44. Walsh M.C., Yao Q., Horbar J.D., et al. Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks. Pediatrics 2006, 118:e1328-e1335.
45. Edwards A.D., Wyatt J.S., Richardson C., et al. Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet 1990, 335:1491-1495.
46. Fowlie P.W., Davis P.G. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2002, (3). CD000174. DOI:10.1002/14651858.CD000174.
47. Schmidt B., Davis P., Moddemann D., et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001, 344(26):1966-1972.
48. Pauker S.G., Kassirer J.P. Decision analysis. N Engl J Med 1987, 316:250-258.
49. Butler W.J., Bohn D.J., Bryan A.C., et al. Ventilation by high-frequency oscillation in humans. Anesth Analg 1980, 59:577-584.
50. Cools F., Henderson-Smart D.J., Offringa M., et al. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev 2009, (3). CD000104. DOI:10.1002/14651858.CD000104.pub3.
51. Jacobs S.E., Hunt R., Tarnow-Mordi W.O., et al. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2007, (4). CD003311. DOI:10.1002/14651858.CD003311.pub2.